Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Conditions: Systemic Lupus Erythematosus; Lupus Nephritis Interventions: Biological: CABA-201 Sponsors: Cabaletta Bio Recruiting

Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials